Russia’s Second Coronavirus Vaccine Passes Early Trials

Russia’s second coronavirus vaccine have reportedly passed early clinical trials and have been proved successful, its developer said Thursday after Russia boasted of approving the world’s first vaccine. Russia’s Vektor a top-secret state virology research centre in Siberia said that early stage trials were successful for its own experimental vaccine, named EpiVacCorona. Vektor’s press department […]

Continue Reading